Friday, April 26, 2013

H7N9: ECDC Epidemiological Update – April 26th

image

Credit ECDC

 

# 7195

 

The ECDC has a new epidemiological update out this morning, which includes the imported case to Taiwan. While not surprising, the `money quote’ from this assessment is:

An increasing incidence of sporadic cases and expansion of geographic spread in China and possibly neighbouring countries are expected over the coming weeks. Individual imported human cases to Europe cannot be ruled out and countries need to prepare for detecting and diagnosing such cases.

 

Follow the link for all of the charts and graphs.

 

 

Epidemiological update of 26 April: avian influenza A(H7N9) virus in China

26 Apr 2013

Avian influenza A(H7N9) in China

ECDC

Since 31 March 2013, one hundred and twelve (112) cases of human infection with avian influenza A(H7N9) virus have been reported from eight provinces in eastern China. Onset of disease has been between 19 February and 18 April 2013 in: Zhejiang (44), Shanghai (33), Jiangsu (24), Henan (4), Anhui (4), Beijing (1), Shandong (1) and Taiwan (1). The date of disease onset is currently unknown for fourteen patients.

 

Most cases have developed severe respiratory disease. Twenty three patients have died (case-fatality ratio=21%). The median age is 62 years with a range between 4 and 91 years; 33 out of 112 patients are female.

 

The Chinese health authorities are responding to this public health event by enhanced surveillance, epidemiological and laboratory investigation and contact tracing. The animal health sector has intensified investigations into the possible sources and reservoirs of the virus. The authorities reported to the World Organisation for Animal Health (OIE) that avian influenza A(H7N9) was detected in samples from pigeons, chickens and ducks, and in environmental samples from live bird markets ('wet markets') in Shanghai, Jiangsu, Anhui and Zhejiang provinces. Authorities have closed markets and culled poultry in affected areas.

 

The source and mode of transmission have not been confirmed. The outbreak is caused by a reassortant avian influenza virus with low pathogenicity for birds, hence it does not cause the signal 'die-offs' in poultry associated with highly pathogenic strains of avian influenza viruses. Genetic analyses of the isolates have shown changes which suggest that the H7N9 virus may have greater ability to infect mammalian species, including humans, than most other avian influenza viruses. Pathogenicity for humans appears to be high and higher age appears to be a risk factor for disease.

 

The most likely scenario is that the influenza A(H7N9) virus is spreading undetected in poultry populations and occasionally infecting humans who have close contact with poultry or poultry products but this will have to be validated as further data become available.

 

At the present time there is no evidence of sustained human-to-human transmission. Close to 2 000 close contacts of confirmed cases are reported to have been followed up. There is one family cluster with two confirmed cases for which human-to-human transmission cannot be ruled out but where common exposure is the most likely explanation. In addition, the virus has been detected in one asymptomatic carrier in Beijing.

 

An increasing incidence of sporadic cases and expansion of geographic spread in China and possibly neighbouring countries are expected over the coming weeks. Individual imported human cases to Europe cannot be ruled out and countries need to prepare for detecting and diagnosing such cases.

 

Critical developments that would change this assessment would be evidence of sustained human-to-human transmission and detection of avian influenza A(H7N9) in bird populations in Europe.

 

ECDC has published the Supporting diagnostic preparedness for detection of avian influenza A(H7N9) viruses in Europe guidance for laboratories on 24 April 2013.

 

ECDC is preparing an EU case definition for A(H7N9).

 

ECDC is closely monitoring developments and is continuously re-assessing the situation in collaboration with WHO, US CDC, China CDC and other partners.

 

This epidemiological update does not change the conclusions and recommendations of the updated risk assessment published on April 12.

Related links:

External links: